Covance, Inc. (CVD) Tops Q2 EPS by 1c; Guides Q3, FY11 EPS In-Line
Tweet
Share
E-mailGet Alerts CVD Hot Sheet
Price: $106.42 --0%
Financial Fact:
Reimbursable out-of-pocket expenses: 43.92M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Reimbursable out-of-pocket expenses: 43.92M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Covance, Inc. (NYSE: CVD) reported Q2 EPS of $0.66, $0.01 better than the analyst estimate of $0.65. Revenue for the quarter came in at $518.2 million versus the consensus estimate of $508.04 million.
Covance, Inc. sees Q3 2011 EPS of $0.70, versus the consensus of $0.71.
Covance, Inc. sees FY2011 EPS of $2.60-$2.80, versus the consensus of $2.73.
Covance, Inc. sees Q3 2011 EPS of $0.70, versus the consensus of $0.71.
Covance, Inc. sees FY2011 EPS of $2.60-$2.80, versus the consensus of $2.73.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- Candel Therapeutics, Inc. (CADL) Misses Q2 EPS by 29c
- Forum Markets, Incorporated (FRMM) Tops Q2 EPS by 29c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
